SynthesisDysphagia2026
Prevalence and Risk Factors of Dysphagia in Patients with Sarcopenia: A Meta-Analysis.
Synthesis in Dysphagia, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association Between Computed-Tomography-Derived Erector Spinae Muscle Characteristics and Swallowing Outcomes in Older Patients with Pneumonia.Healthcare (Basel, Switzerland) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Sarcopenia is a progressive skeletal muscle disorder characterized by the loss of muscle mass and function, which has been associated with an increased risk of dysphagia. Although previous studies have established an association between sarcopenia and dysphagia, the precise prevalence of dysphagia in patients with sarcopenia remains inadequately determined. This study aims to investigate the prevalence and risk factors of dysphagia in patients with sarcopenia. We systematically searched the PubMed, Embase, Cochrane Library, Medline, Web of Science, Scopus, CNKI, Wan Fang, and CBM for studies related to sarcopenia and dysphagia published from the establishment of the databases until January 16, 2025. Relevant literature on the coexistence of sarcopenia and dysphagia was retrieved, followed by a meta-analysis performed using Stata 15.0. The prevalence and risk factors of dysphagia in patients with sarcopenia were analyzed. A total of 24 studies comprising 9,543 patients were included in the analysis. The pooled prevalence of dysphagia in patients with sarcopenia was 31% (95% confidence interval [CI]: 0.22-0.40). Age (OR = 1.65, 95% CI: 0.75-3.66), tongue strength (OR = 0.96, 95% CI: 0.89-1.04), and malnutrition (OR = 1.83, 95% CI: 0.46-7.26) were identified as major risk factors for dysphagia in patients with sarcopenia. In conclusion, the prevalence of dysphagia in patients with sarcopenia was 31%, with age, tongue strength, and malnutrition identified as primary risk factors. However, due to the limited number of studies included and the failure to combine multiple individual risk factors, the clinical significance needs further investigation. Future multi-regional studies are required to confirm these factors.
Indexed as
Identifiers
41191046What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.